The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
High recurrence risk in pT1bc HER2-positive, triple-negative, node-negative early breast cancer patients.
A. Vaccaro
No relevant relationships to disclose
F. Ciancola
No relevant relationships to disclose
L. Pizzuti
No relevant relationships to disclose
I. Sperduti
No relevant relationships to disclose
L. Moscetti
No relevant relationships to disclose
P. Vici
No relevant relationships to disclose
F. Longo
No relevant relationships to disclose
E. Ruggeri
No relevant relationships to disclose
M. Di Seri
No relevant relationships to disclose
M. A. Giampaolo
No relevant relationships to disclose
T. Gamucci
No relevant relationships to disclose